Drug Approval | June 12, 2024
IOL Chemicals receives EDQM CEP certificate for Pantoprazole Sodium Sesquihydrate and Allopurinol
EDQM has also issued a Certificate of Suitability for Allopurino
EDQM has also issued a Certificate of Suitability for Allopurino
Abbott's first-of-its-kind i2i technology enables synchronized communication between two leadless pacemakers
The new brand identity embodies Neuland's unwavering commitment to innovation, integrity, collaboration, and progress
Ashkenazi will continue to serve at full capacity in her role and as a member of Lilly's Executive Committee through July 2024
HaystackAnalytics is engaged in the business of developing genomic analysis software
The transaction aligns with Lupin's strategy to grow its global presence in Specialty areas
DCGI has also granted permission to manufacture and market FDF of Cefepime and Enmetazobactam as a dry powder injectable
The special Tele MANAS cell to serve as a dedicated mental health assistance helpline for all Armed Forces beneficiaries across country
Updated analysis from Memorial Sloan Kettering Cancer Center presented at ASCO 2024 has expanded to 42 patients with clinical complete response
This novel recombinant has been developed and is a patented novel recombinant Human Albumin 20% process
Subscribe To Our Newsletter & Stay Updated
